Noninvasive Prenatal Testing Market 2020 Size, Dynamics & Forecast Report to 2027
Noninvasive Prenatal Testing Market report published by Value Market Research, which studies the future outlook of the market. It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2019-2027. The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genesis Genetics (CooperSurgical, Inc.), Centogene N.V., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd (Ariosa Diagnostics), Progenity, Inc., Laboratory Corp. of America Holdings, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), MedGenome Labs Ltd., Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.), QiagenQuest Diagnostics, Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, ...